AYTU

AYTU BioPharma Inc
2.18
0.13 (6.34%)

Aytu BioPharma Inc. (AYTU) Fundamentals

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments BioPharma and Consumer Health segments of which it generates maximum revenue from the BioPharma segment.
SHARE INFORMATION
Market CapUS$ 7,593,182
Shares Outstanding3,573,262
Float3,482,046
Percent Float97.45%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 96,669,000
Latest Fiscal EPSUS$ -486.74
Latest Fiscal Date2022-06-30
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions75
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months1,317,092
Institutional Holdings Percent17.2%
Institutional Sold Previous 3 Months263,063
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months218,871
Insider Holdings Percent6.7
Insider Sold Previous 3 Months535,608
Insider Shares Owned4,195,206
TRADING INFO
52 Week HighUS$ 23.20
52 Week LowUS$ 1.95
52 Week High ChangeUS$ -90.68
21 Day Moving AverageUS$ 2.4366
21 Day Extended Moving AverageUS$ 2.4432
50 Day Moving AverageUS$ 2.9342
50 Day Extended Moving AverageUS$ 2.8687
200 Day Moving AverageUS$ 5.3948
200 Day Extended Moving AverageUS$ 8.6649
10 Day Average Volume55,369
20 Day Average Volume66,346
30 Day Average Volume61,285
50 Day Average Volume73,342
Alpha-0.064529
Beta-0.3976
Standard Deviation0.327872
R20.004265
7 Day Price ChangeUS$ -0.225
7 Day Percent Change-9.57%
21 Day Price ChangeUS$ -0.505
21 Day Percent Change-19.2%
30 Day Price ChangeUS$ -0.645
30 Day Percent Change-23.29%
Month to Date Price ChangeUS$ -0.535
Month to Date Percent Change-20.11%
Quarter to Date Price ChangeUS$ -1.66
Quarter to Date Percent Change-43.78%
180 Day Price ChangeUS$ -1.72
180 Day Percent Change-44.72%
200 Day Price ChangeUS$ -2.46
200 Day Percent Change-53.6%
Year to Date Price ChangeUS$ -1.66
Year to Date Percent Change-43.78%

Aytu BioPharma Inc. (AYTU) Key Ratios

PROFITABILITY
EBIT Margin-21.2%
EBITDA Margin-12.3%
Pre-Tax Profit Margin-172.8%
Profit Margin Count-73.37%
Gross Margin59.5%
Profit Margin TOT-73.37%
INCOME STATEMENTS
RevenueUS$ 105,581,000
Revenue Per ShareUS$ 29.5475
Revenue (3 Years)US$ 86.75
Revenue (5 Years)US$ 105.72
FINANCIAL STRENGTH
Price to Tangible Book-0.40
Total Debt To Equity0.50
Int Coverage0.00
Current Ratio1.10
Leverage Ratio2.90
Quick Ratio0.70
Long Term Debt To Capital0.24
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 9,983,384
Price to Sales0.071918
Price to Free Cash-0.30
PE High Last 5 Years-0.30
Price To Book0.20
Price To Cash Flow0.00
PE Low Last 5 Years-1.50
Price to Tangible Book-0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.40
Invoice Turnover2.60
Assets Turnover0.60
Return Assets-44.34
Return on Equity-107.54
Return on Capital-77.79

Aytu BioPharma Inc. (AYTU) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPlante & Moran, PLLC
CEOJoshua R. Disbrow
Emplyoees164
Last AuditUE
CIK0001385818
IndustryDrug Manufacturers
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address373 Inverness Parkway
Suite 206
Englewood, CO 80112
Websitehttps://www.aytubio.com
Facsimile-
Telephone+1 720 437-6580
Emailinfo@aytubio.com
Your Recent History
NASDAQ
AYTU
AYTU BioPh..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 10:40:17